AADAC Polyclonal Antibody, PE-Cy7 Conjugated
Cat# bs-11384R-PE-Cy7
Size : 100ul
Contact local distributor :
AADAC Polyclonal Antibody, PE-Cy7 Conjugated
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-11384r-pe-cy7-100ul |
| Product Name | AADAC Polyclonal Antibody, PE-Cy7 Conjugated |
| Applications | WB |
| Reactivity | Mouse, Rat |
| Predicted Reactivity | Human, Cow, Sheep, Pig, Horse, Rabbit |
| Specifications | |
| Conjugation | PE-Cy7 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human AADAC |
| Immunogen Range | 228-273/399 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 13 |
| Swiss Prot | P22760 |
| Subcellular location | Cytoplasm, Cell membrane |
| Synonyms | DAC; CES5A1; Arylacetamide deacetylase; AADAC |
| Background | Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity. |
| Application Dilution | |
| WB | 1:300-5000 |